147 related articles for article (PubMed ID: 36209449)
1. Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.
Yap S; Vassallo A; Goldsbury D; O'Connell DL; Brand A; Emery J; DeFazio A; Canfell K; Steinberg J
Cancer Causes Control; 2023 Jan; 34(1):47-58. PubMed ID: 36209449
[TBL] [Abstract][Full Text] [Related]
2. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
Laaksonen MA; Arriaga ME; Canfell K; MacInnis RJ; Byles JE; Banks E; Shaw JE; Mitchell P; Giles GG; Magliano DJ; Gill TK; Klaes E; Velentzis LS; Hirani V; Cumming RG; Vajdic CM
Gynecol Oncol; 2019 Jun; 153(3):580-588. PubMed ID: 30935715
[TBL] [Abstract][Full Text] [Related]
3. The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
[TBL] [Abstract][Full Text] [Related]
4. Nut and peanut butter intake are not directly associated with the risk of endometrial or ovarian cancer: Results from a Dutch prospective cohort study.
Nieuwenhuis L; van den Brandt PA
Clin Nutr; 2020 Jul; 39(7):2202-2210. PubMed ID: 31601449
[TBL] [Abstract][Full Text] [Related]
5. Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.
Goldsbury DE; Vassallo A; Weber MF; Steinberg J; Webb PM; DeFazio A; Canfell K
PLoS One; 2023; 18(4):e0282851. PubMed ID: 37071628
[TBL] [Abstract][Full Text] [Related]
6. The effect of statins on risk and survival of gynecological malignancies.
Lavie O; Pinchev M; Rennert HS; Segev Y; Rennert G
Gynecol Oncol; 2013 Sep; 130(3):615-9. PubMed ID: 23718932
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
8. Socio-demographic factors, comorbidity and diagnostic delay among women diagnosed with cervical, endometrial or ovarian cancer.
Robinson KM; Christensen KB; Ottesen B; Krasnik A
Eur J Cancer Care (Engl); 2011 Sep; 20(5):653-61. PubMed ID: 21771126
[TBL] [Abstract][Full Text] [Related]
9. The effect of bisphosphonates on the risk of endometrial and ovarian malignancies.
Rennert G; Rennert HS; Pinchev M; Lavie O
Gynecol Oncol; 2014 May; 133(2):309-13. PubMed ID: 24556062
[TBL] [Abstract][Full Text] [Related]
10. Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective.
Woodward ER; Sleightholme HV; Considine AM; Williamson S; McHugo JM; Cruger DG
BJOG; 2007 Dec; 114(12):1500-9. PubMed ID: 17903229
[TBL] [Abstract][Full Text] [Related]
11. Registry-derived stage (RD-Stage) for capturing cancer stage at diagnosis for endometrial cancer.
Evans SM; Ivanova K; Rome R; Cossio D; Pilgrim C; Zalcberg J; Antill Y; Blake L; Du Guesclin A; Garrett A; Giffard D; Golobic N; Moir D; Parikh S; Parisi A; Sanday K; Shadbolt C; Smith M; Te Marvelde L; Williams K
BMC Cancer; 2023 Dec; 23(1):1222. PubMed ID: 38087227
[TBL] [Abstract][Full Text] [Related]
12. Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.
Trabert B; Aarestrup J; Ulrich LG; Wentzensen N; Sørensen TIA; Baker JL
Gynecol Oncol; 2018 Mar; 148(3):547-552. PubMed ID: 29331371
[TBL] [Abstract][Full Text] [Related]
13. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer.
Vuento MH; Stenman UH; Pirhonen JP; Mäkinen JI; Laippala PJ; Salmi TA
Gynecol Oncol; 1997 Jan; 64(1):141-6. PubMed ID: 8995563
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of the data collection process for a multicenter, population-based, case-control design.
Wingo PA; Ory HW; Layde PM; Lee NC
Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
[TBL] [Abstract][Full Text] [Related]
16. Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.
Gerritzen LH; Hoogerbrugge N; Oei AL; Nagengast FM; van Ham MA; Massuger LF; de Hullu JA
Fam Cancer; 2009; 8(4):391-7. PubMed ID: 19504173
[TBL] [Abstract][Full Text] [Related]
17. Risk of endometrial cancer among women with benign ovarian tumors - A Danish nationwide cohort study.
Reinholdt K; Kjaer SK; Guleria S; Frederiksen K; Mellemkjær L; Munk C; Jensen A
Gynecol Oncol; 2020 May; 157(2):549-554. PubMed ID: 32139149
[TBL] [Abstract][Full Text] [Related]
18. Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature.
Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB
Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254
[TBL] [Abstract][Full Text] [Related]
19. Synchronous endometrioid endometrial and ovarian cancer in a 34-year-old woman.
Amaral PI; Silva A; Lacerda A; Barros C
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26351313
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
